Skip to main content
Top
Published in: Diabetologia 9/2011

Open Access 01-09-2011 | Short Communication

Quantitative EEG in type 1 diabetic adults with childhood exposure to severe hypoglycaemia: a 16 year follow-up study

Authors: B. O. Åsvold, T. Sand, K. A. Hestad, M. R. Bjørgaas

Published in: Diabetologia | Issue 9/2011

Login to get access

Abstract

Aims/hypothesis

In diabetic children and adolescents, a history of severe hypoglycaemia (SH) has been associated with increased slow EEG activity and reduced cognition, possibly due to harmful effects of SH on the developing brain. In a group of type 1 diabetic patients with early exposure to SH, who had EEG abnormalities and reduced cognition in childhood, we have recently demonstrated that the reduced cognition may persist into adulthood. We have now assessed whether the reduced cognition was accompanied by lasting EEG abnormalities.

Methods

In 1992–1993, we studied EEG and cognition in 28 diabetic children and 28 matched controls. 16 years later, we re-investigated the same participants, with 96% participation rate. Diabetic participants were classified as with (n = 9) or without (n = 18) early SH, defined as episodes with convulsions or loss of consciousness by 10 years of age. For each EEG band (delta, theta, alpha and beta) and cerebral region (frontocentral, temporal, and parietooccipital), we calculated relative amplitudes and amplitude asymmetry. We also calculated occipital alpha mean frequency, alpha peak frequency at maximum amplitude, alpha peak width, and theta regional mean frequencies. We examined whether these EEG measures, relative to age- and sex-matched controls, differed between diabetic participants with and without early SH.

Results

We found no association of early SH with any of the EEG measures.

Conclusions/interpretation

Childhood SH was not associated with EEG abnormalities in young type 1 diabetic adults. Our findings suggest that the reduced adulthood cognition associated with childhood exposure to SH is not accompanied by lasting EEG abnormalities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bjorgaas M, Gimse R, Vik T, Sand T (1997) Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 86:148–153PubMedCrossRef Bjorgaas M, Gimse R, Vik T, Sand T (1997) Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 86:148–153PubMedCrossRef
2.
go back to reference Bjorgaas M, Sand T, Gimse R (1996) Quantitative EEG in type 1 diabetic children with and without episodes of severe hypoglycemia: a controlled, blind study. Acta Neurol Scand 93:398–402PubMedCrossRef Bjorgaas M, Sand T, Gimse R (1996) Quantitative EEG in type 1 diabetic children with and without episodes of severe hypoglycemia: a controlled, blind study. Acta Neurol Scand 93:398–402PubMedCrossRef
3.
go back to reference Haumont D, Dorchy H, Pelc S (1979) EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 18:750–753CrossRef Haumont D, Dorchy H, Pelc S (1979) EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 18:750–753CrossRef
4.
go back to reference Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J, Brismar T (2005) EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia 48:412–419PubMedCrossRef Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J, Brismar T (2005) EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia 48:412–419PubMedCrossRef
5.
go back to reference Soltesz G, Acsadi G (1989) Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996PubMedCrossRef Soltesz G, Acsadi G (1989) Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996PubMedCrossRef
6.
go back to reference Northam EA, Lin A (2010) Hypoglycaemia in childhood onset type 1 diabetes—part villain, but not the only one. Pediatr Diabetes 11:134–141PubMedCrossRef Northam EA, Lin A (2010) Hypoglycaemia in childhood onset type 1 diabetes—part villain, but not the only one. Pediatr Diabetes 11:134–141PubMedCrossRef
7.
go back to reference Asvold BO, Sand T, Hestad K, Bjorgaas MR (2010) Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 33:1945–1947PubMedCrossRef Asvold BO, Sand T, Hestad K, Bjorgaas MR (2010) Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study. Diabetes Care 33:1945–1947PubMedCrossRef
8.
go back to reference Tupola S, Saar P, Rajantie J (1998) Abnormal electroencephalogram at diagnosis of insulin-dependent diabetes mellitus may predict severe symptoms of hypoglycemia in children. J Pediatr 133:792–794PubMedCrossRef Tupola S, Saar P, Rajantie J (1998) Abnormal electroencephalogram at diagnosis of insulin-dependent diabetes mellitus may predict severe symptoms of hypoglycemia in children. J Pediatr 133:792–794PubMedCrossRef
9.
go back to reference Hauser E, Strohmayer C, Seidl R, Birnbacher R, Lischka A, Schober E (1995) Quantitative EEG in young diabetics. J Child Neurol 10:330–334PubMedCrossRef Hauser E, Strohmayer C, Seidl R, Birnbacher R, Lischka A, Schober E (1995) Quantitative EEG in young diabetics. J Child Neurol 10:330–334PubMedCrossRef
10.
go back to reference Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M, Schabmann A (2000) Decrease of vigilance assessed by EEG-mapping in type I diabetic patients with history of recurrent severe hypoglycaemia. Psychoneuroendocrinology 25:85–105PubMedCrossRef Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M, Schabmann A (2000) Decrease of vigilance assessed by EEG-mapping in type I diabetic patients with history of recurrent severe hypoglycaemia. Psychoneuroendocrinology 25:85–105PubMedCrossRef
Metadata
Title
Quantitative EEG in type 1 diabetic adults with childhood exposure to severe hypoglycaemia: a 16 year follow-up study
Authors
B. O. Åsvold
T. Sand
K. A. Hestad
M. R. Bjørgaas
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2208-3

Other articles of this Issue 9/2011

Diabetologia 9/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.